Description

Rigevidon (levonorgestrel, ethinyl estradiol) Coated Tablets №63

Ingredients

Each tablet contains:

• Levonorgestrel: X mg
• Ethinyl Estradiol: Y mg

Dosage

The recommended dosage is:

• Take one tablet daily for 21 days, then take no tablets for 7 days.
• Start the next pack after the 7 tablet-free days, even if the menstrual period has not finished.

Indications

Rigevidon tablets are indicated for:

• Pregnancy prevention
• Regulating menstrual cycles

Contraindications

Do not use Rigevidon if:

• You are pregnant or breastfeeding
• You have a history of blood clots

Directions

Follow these directions for optimal results:

• Take the tablet at the same time each day.
• If you miss a dose, refer to the package leaflet for instructions.

Scientific Evidence

Rigevidon has been extensively studied in clinical trials, demonstrating its effectiveness in preventing pregnancy and regulating menstrual cycles. Research published in the Journal of Contraception highlighted the high efficacy of Rigevidon in pregnancy prevention, with a low incidence of side effects compared to other oral contraceptives.

The pharmacological action of Rigevidon involves the suppression of ovulation, thickening of cervical mucus to prevent sperm penetration, and alteration of the endometrium to inhibit implantation. These mechanisms collectively contribute to its contraceptive effects.

Additional Information

It is essential to consult a healthcare provider before starting Rigevidon to ensure it is suitable for your individual health needs. While Rigevidon is generally well-tolerated, common side effects may include nausea, breast tenderness, and changes in menstrual bleeding patterns. If you experience severe side effects, seek medical advice promptly.

Always read the patient information leaflet provided with the medication for detailed instructions on usage, potential side effects, and what to do in case of missed doses. Proper adherence to the prescribed regimen is crucial for the effectiveness of Rigevidon in pregnancy prevention and cycle regulation.